US Bancorp’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-18,327
Closed -$3.37M 4204
2021
Q2
$3.37M Sell
18,327
-9,451
-34% -$1.74M 0.01% 698
2021
Q1
$4.25M Sell
27,778
-2,782
-9% -$425K 0.01% 595
2020
Q4
$4.78M Sell
30,560
-208
-0.7% -$32.5K 0.01% 549
2020
Q3
$3.52M Sell
30,768
-375
-1% -$42.9K 0.01% 572
2020
Q2
$3.5M Sell
31,143
-1,324
-4% -$149K 0.01% 570
2020
Q1
$2.92M Sell
32,467
-2,349
-7% -$211K 0.01% 567
2019
Q4
$3.77M Sell
34,816
-761
-2% -$82.3K 0.01% 594
2019
Q3
$3.48M Buy
35,577
+172
+0.5% +$16.8K 0.01% 597
2019
Q2
$4.64M Sell
35,405
-923
-3% -$121K 0.01% 534
2019
Q1
$4.91M Sell
36,328
-3,400
-9% -$460K 0.01% 501
2018
Q4
$3.87M Sell
39,728
-635
-2% -$61.8K 0.01% 525
2018
Q3
$5.61M Buy
40,363
+6,696
+20% +$931K 0.02% 474
2018
Q2
$4.18M Buy
33,667
+2,567
+8% +$319K 0.01% 552
2018
Q1
$3.47M Buy
31,100
+933
+3% +$104K 0.01% 598
2017
Q4
$3.61M Sell
30,167
-1,577
-5% -$189K 0.01% 593
2017
Q3
$4.45M Buy
31,744
+3,607
+13% +$506K 0.01% 521
2017
Q2
$3.42M Sell
28,137
-11,045
-28% -$1.34M 0.01% 584
2017
Q1
$4.75M Sell
39,182
-1,177
-3% -$143K 0.02% 496
2016
Q4
$4.94M Sell
40,359
-6,025
-13% -$737K 0.02% 469
2016
Q3
$5.68M Sell
46,384
-2,751
-6% -$337K 0.02% 435
2016
Q2
$5.74M Buy
49,135
+5,813
+13% +$679K 0.02% 417
2016
Q1
$6.03M Sell
43,322
-7,321
-14% -$1.02M 0.02% 412
2015
Q4
$9.66M Sell
50,643
-2,156
-4% -$411K 0.04% 333
2015
Q3
$8.26M Sell
52,799
-5,973
-10% -$934K 0.03% 361
2015
Q2
$10.6M Buy
58,772
+5,342
+10% +$966K 0.04% 324
2015
Q1
$9.26M Sell
53,430
-2,623
-5% -$455K 0.04% 348
2014
Q4
$10.4M Buy
56,053
+611
+1% +$113K 0.04% 330
2014
Q3
$9.19M Buy
55,442
+5,680
+11% +$942K 0.04% 334
2014
Q2
$7.78M Buy
49,762
+2,394
+5% +$374K 0.03% 365
2014
Q1
$7.21M Buy
47,368
+2,042
+5% +$311K 0.03% 370
2013
Q4
$6.02M Buy
45,326
+817
+2% +$109K 0.02% 382
2013
Q3
$5.17M Sell
44,509
-2,035
-4% -$236K 0.02% 401
2013
Q2
$4.29M Buy
+46,544
New +$4.29M 0.02% 416